JAKARTA, Indonesia, Feb. 18, 2016 /PRNewswire/ -- The pull factor of Indonesia's pharmaceutical market is increasingly shifting from leveraging its celebrated potential to actual realities on the ground. The country's expanding middle class, its growing and ageing population and the implementation of a series of policy packages including the public health insurance all spur a current rising demand for healthcare services and pharmaceuticals in particular.
For foreign investors, which the government announced on February 11th will soon be allowed to own 100% of local companies, a key driver is the possibility to access Indonesia's 250m strong population and other ASEAN countries to which Indonesian exports do not have to pay import duties. Therefore sales to the region become an increasingly interesting proposition for higher-value brands, where the sourcing of raw materials has less impact on total costs.
These and other positive factors have contributed to the international expansion of CPhI SEA, the only trade exhibition dedicated to the pharma industry in the region, held at Jakarta International Expo during April 6-8, 2016. New global exhibitors like Catalent, Croda or Tecnomaco, join an already crowded group made of companies like Evonik, Colorcon, Bahrain Pharma and Clariant.
Don't miss the opportunity to be part of the change, register here and join the event!
The CPhI series of events drives growth and innovation in the global pharmaceutical industry, with leading exhibitions and online communities covering every step of the supply chain from drug discovery to finished dosage.
More than 100,000 visitors meet over 6,000 exhibitors at events in Europe, China, India, Japan, South East Asia, Russia, Brazil, Istanbul and Korea every year to exchange ideas, form alliances and conduct business on an international scale. CPhI also provides an online buyer & supplier directory at CPhI-Online.com.
Contact Person: Ivan Ferrari
Phone Number: +62 21 2930 5959 ext 138
SOURCE CPhI SEA - UBM